{"id":"W2414307865","doi":"10.1200/jco.2015.33.15_suppl.e13534","title":"Development of a proposed biosimilar product based on the demonstration of physicochemical, pharmacologic and clinical similarity to pegfilgrastim.","year":2015,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Apotex (Canada)","funders":"","keywords":"Biosimilar; Medicine; Pegfilgrastim; Cmax; Filgrastim; Oncology; Phases of clinical research; Confidence interval; Pharmacology; Internal medicine; Clinical trial; Pharmacokinetics; Chemotherapy; Neutropenia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01217027,0.0001836965,0.001406603,0.00009662221,0.00005871584,0.000005301743,0.0003733305,0.0005377863,0.00009001058],"category_scores_gemma":[0.009115195,0.000100527,0.0003559942,0.0002290378,0.001067469,0.00004263626,0.0001152133,0.001120193,0.000006321792],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004719237,"about_ca_system_score_gemma":0.001837942,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00000193257,"about_ca_topic_score_gemma":0.000005073711,"domain_scores_codex":[0.9942197,0.002002436,0.00308084,0.0002906009,0.0001682737,0.0002381423],"domain_scores_gemma":[0.9923624,0.004563234,0.001908234,0.0002244968,0.0007555901,0.0001860663],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.02807922,0.0207564,0.05648147,0.0001726762,0.002454755,0.00005026915,0.0005114586,0.00005783556,0.4558898,0.00092442,0.05591215,0.3787096],"study_design_scores_gemma":[0.01535532,0.03609084,0.09627247,0.0003261468,0.001410888,0.00007258333,0.0005688611,0.0006285869,0.754791,0.001128581,0.0928192,0.0005355917],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9777657,0.0002497989,0.001253647,0.01837201,0.001192873,0.0004603541,0.0000114818,0.000008237404,0.000685938],"genre_scores_gemma":[0.9565204,0.00005009287,0.0407055,0.002520034,0.0001657186,0.000002924148,0.000002060429,0.000008111897,0.00002510964],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.378174,"threshold_uncertainty_score":0.9992315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2740587639147554,"score_gpt":0.490525259223902,"score_spread":0.2164664953091466,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}